{"cik":1778922,"taxonomy":"us-gaap","tag":"LiabilitiesCurrent","label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","entityName":"SpyGlass Pharma, Inc.","units":{"USD":[{"end":"2024-12-31","val":7791000,"accn":"0001778922-26-000020","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26","frame":"CY2024Q4I"},{"end":"2025-12-31","val":8584000,"accn":"0001778922-26-000020","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-26"},{"end":"2025-12-31","val":8584000,"accn":"0001778922-26-000035","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14","frame":"CY2025Q4I"},{"end":"2026-03-31","val":6667000,"accn":"0001778922-26-000035","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14","frame":"CY2026Q1I"}]}}